Order Article Reprints

Shionoya K, Sofuni A, Mukai S, Yamauchi Y, Tsuchiya T, Tanaka R, Tonozuka R, Yamamoto K, Nagai K, Matsunami Y, et al. Initial Use Experience of Durvalumab Plus Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer in a Japanese Territory Center. Cancers. 2025; 17(2):314. https://doi.org/10.3390/cancers17020314

Shionoya, Kento, Atsushi Sofuni, Shuntaro Mukai, Yoshiya Yamauchi, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Kenjiro Yamamoto, Kazumasa Nagai, Yukitoshi Matsunami, and et al. 2025. "Initial Use Experience of Durvalumab Plus Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer in a Japanese Territory Center" Cancers 17, no. 2: 314. https://doi.org/10.3390/cancers17020314

Shionoya, K., Sofuni, A., Mukai, S., Yamauchi, Y., Tsuchiya, T., Tanaka, R., Tonozuka, R., Yamamoto, K., Nagai, K., Matsunami, Y., Kojima, H., Minami, H., Hirakawa, N., Zhan, Q., & Itoi, T. (2025). Initial Use Experience of Durvalumab Plus Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer in a Japanese Territory Center. Cancers, 17(2), 314. https://doi.org/10.3390/cancers17020314